Verastem Oncology
VSTM
#7578
Rank
C$0.44 B
Marketcap
$9.99
Share price
4.02%
Change (1 day)
-30.50%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2024 (TTM): -C$0.13 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are C$10 Million. In 2023 the company made an earning of -C$0.13 Billion a decrease over its 2022 earnings that were of -C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.13 Billion0.64%
2023 -C$0.13 Billion18.36%
2022 -C$0.11 Billion3.67%
2021 -C$0.11 Billion5.43%
2020 -C$96.66 Million-54.74%
2019 -C$0.22 Billion105.99%
2018 -C$0.11 Billion6.83%
2017 -C$97.04 Million86.06%
2016 -C$52.16 Million-37.03%
2015 -C$82.82 Million8.43%
2014 -C$76.38 Million29.52%
2013 -C$58.97 Million28.6%
2012 -C$45.86 Million133.9%
2011 -C$19.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$64.14 Million-52.05%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.90 B-11,991.41%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.67 B-1,349.60%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.28 B-4,802.36%๐Ÿ‡ฌ๐Ÿ‡ง UK